Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

Thomas J. Walsh(Cornell University), John R. Perfect(Duke University), Arnold Louie(Albany Medical Center Hospital), David A. Stevens(Stanford University), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), Ray Hachem(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Lisa D. Pedicone, Raoul Herbrecht(Institut de Cancérologie Strasbourg), Amelia Langston(CancerCare Manitoba), Gavin Corcoran, Susan Hadley(Tufts Medical Center), Charles S. White(University of Maryland, Baltimore), Gerald R. Donowitz(University of Virginia), Brahm H. Segal(Roswell Park Comprehensive Cancer Center), Jagadish Gogate(Memorial Hospital of Rhode Island), C. Hardalo, Richard Graybill(The University of Texas at San Antonio Health Science Center), Patricia Ribaud(Hôpital Saint-Louis), Reginald E. Greene, Pranatharthi Chandrasekar(Wayne State University), Jo‐Anne H. van Burik(University of Minnesota), Gopal Krishna(University of Maryland, Baltimore)
Clinical Infectious Diseases
December 1, 2006
Cited by 752


Related Papers